Core update as of June 26, 2026

The CORE update lists nine outbreak and adverse event postings. A new outbreak of Clostridium botulinum (ref #1383) linked to a Nara Organics Whole Milk Powdered Infant Formula has been added to the table. On June 13, 2026, Nara Organics announced a recall, and the FDA issued an advisory. The FDA has initiated a traceback. The CDPH IBTPP reported three toxin type A infections among infants consuming Nara Organics Whole Milk Organic Powdered Infant Formula with illness onset between April and May 2026. On June 13, 2026, Nara Organics agreed to recall all of its Nara Organics brand Whole Milk Organic Powdered Infant Formula. All of Nara Organics' formula was manufactured in Europe. A new outbreak of Cyclospora (ref #1381) linked to an unidentified product has been added to the table. The FDA has initiated a traceback. The outbreak of Salmonella Enteritidis (ref #1378) linked to an unidentified product has increased the case count from 62 to 68. For the Listeria monocytogenes outbreak (ref #1380) linked to requeson/soft ricotta cheese, the FDA updated the outbreak advisory on June 12 and 15, 2026, to include retail sites for some recalled products, expand the recall to all Clover Hill Dairy cheese products, and provide sampling updates. For the Cyclospora outbreak (ref #1375) linked to an unidentified product, the outbreak has ended. The outbreak of Salmonella typhimurium and Newport (ref #1358) linked to moringa leaf powder, the FDA updated the outbreak advisory on June 12, 2026, with additional recalled lots. On June 11, 2026, Total Nutrition Inc., of Deer Park, NY, expanded its recall a second time to include additional lots of TNVitamins and Doctor's Pride Moringa Powder Capsules. @ https://www.fda.gov/food/outbreaks-foodborne-illness/investigations-foodborne-illness-outbreaks?utm_medium=email&utm_source=govdelivery

 

 

 

 Investigations of Foodborne Illness Outbreaks
Investigations of Foodborne Illness Outbreaks

The following is a list of outbreak and adverse event investigations primarily being managed by FDA’s CORE Response Teams.

No comments

Leave a Reply